Table 1 Demographics and CBC parameters for BPH, PL, and PC subjects.
From: Associations between plasma and urinary heavy metal concentrations and the risk of prostate cancer
Variable | BPH (n = 61) | PL (n = 15) | PC (n = 78) | p |
|---|---|---|---|---|
Age | 68 (64–75) | 69 (65–72) | 74 (69–77) | 0.002 |
Total PSA (ng/mL) | 5.9 (3.3–9.4) | 4.4 (1.2–6) | 7.5 (5.4–14) | 0.0002 |
WBC (103/µL) | 7.1 ± 1.7 | 7.5 ± 2.7 | 7.1 ± 1.9 | 0.95 |
RBC (106/µL) | 5.2 ± 0.63 | 5.3 ± 0.77 | 5 ± 0.7 | 0.29 |
HGB (g/dL) | 15 (14–16) | 14 (14–15) | 14 (13–15) | 0.019 |
Neutrophils (103/µL) | 4.2 ± 1.3 | 4.4 ± 1.9 | 4.3 ± 1.5 | 0.87 |
Lymphocytes (103/µL) | 2.1 (1.6–2.7) | 1.9 (1.6–2.3) | 1.9 (1.5–2.3) | 0.47 |
Monocytes (103/µL) | 0.5 (0.4–0.5) | 0.5 (0.4–0.6) | 0.4 (0.4–0.5) | 0.31 |
LUC counts (103/µL) | 0.1 (0.1–0.2) | 0.1 (0.1–0.2) | 0.1 (0.1–0.2) | 0.17 |
PLT (103/µL) | 225 ± 52 | 218 ± 50 | 218 ± 60 | 0.78 |
MPV (fL) | 8.8 ± 0.71 | 8.8 ± 0.83 | 8.8 (8.2–9.2) | 0.99 |
PCT (%) | 1.9 (1.6–2.3) | 2 ± 0.48 | 1.9 ± 0.53 | 0.89 |
MPR | 0.04 (0.03–0.05) | 0.042 ± 0.011 | 0.04 (0.03–0.05) | 0.98 |
NLR | 2 (1.6–2.5) | 2.4 ± 1.1 | 2.3 ± 0.85 | 0.38 |
MLR | 0.22 ± 0.07 | 0.3 ± 0.1 | 0.25 ± 0.079 | 0.03 |
SIRI | 0.94 (0.68–1.1) | 1.1 (0.83–1.8) | 0.92 (0.75–1.4) | 0.27 |
